4.2 Review

Diagnostic imaging of pancreatic neuroendocrine neoplasms (pNEN): tumor detection, staging, prognosis, and response to treatment

期刊

ACTA RADIOLOGICA
卷 57, 期 3, 页码 260-270

出版社

SAGE PUBLICATIONS LTD
DOI: 10.1177/0284185115579932

关键词

Neuroendocrine neoplasm; detection; staging; treatment response; computed tomography (CT); magnetic resonance imaging (MRI)

资金

  1. Bayer Healthcare
  2. Novartis
  3. Ipsen Pharma
  4. Pfizer
  5. Lexicon Pharmaceuticals
  6. ITM Isotope Technologies Munich
  7. Nordion
  8. Affibody AG
  9. Ipsen Healthcare

向作者/读者索取更多资源

Pancreatic neuroendocrine neoplasms (pNEN) are rare malignancies arising from neuroendocrine cells of the pancreas. Functional tumors can present with specific clinical syndromes due to hormonal secretion. These tumors can present as incidental findings on imaging performed for unrelated purposes or they are diagnosed when workup is initiated in patients with specific syndromes or metastases. This article presents an overview of available imaging techniques focusing on computed tomography and magnetic resonance imaging. Recommendations regarding examination protocols are given. Typical imaging features of pNEN and metastases are described. Their potential value for the evaluation of prognosis as well as tumor response under treatment is discussed.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据